Sidley Austin LLP advises biotech, biopharma, medical devices, and healthcare companies across the product lifecycle, with remarkable strength in regulatory and transactional matters. Its regulatory practice ensures client compliance across the marketing authorization, manufacturing, supply chain, distribution, and market access phases. On the transactional side, it handles high-value M&A and IPOs, as well as licensing agreements. The practice is led by San Francisco-based Sharon Flanagan, vastly experienced in corporate and capital markets transactions and governance matters. Washington DC’s Torrey Cope is another key member in the practice, specializing in FDA regulatory issues. Transactional lawyer Jon Olsen joined the San Diego team from Goodwin.
Legal 500 redaktioneller Kommentar

Kernmandanten

  • Hoffmann-La Roche Inc.
  • Johnson & Johnson
  • Illumina, Inc.
  • Biodesix
  • Radiology Partners, Inc.
  • Ocuphire
  • Nektar Therapeutics
  • RAPT Therapeutics
  • Biolojic Design
  • Sagard Healthcare

Highlight-Mandate

  • Represented Chong Kun Dang Corp. in a US$1.3 billion biobucks out-licensing of its proprietary therapeutic to Novartis AG, granting it the rights to develop and commercialize CKD-510, an HDAC6 inhibitor.
  • Represented underwriters Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, Stifel, Nicolaus & Company, and RBC Capital Markets, LLC in connection with the US$110 million initial public offering (IPO) of Contineum Therapeutics, Inc. (“Contineum”), a clinical-stage biopharmaceutical company.
  • Advising Medical Information Working Group, a coalition of major biopharmaceutical and medical device firms, which has been the industry leader in advocating for changes in FDA policy since 2006.

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Praxisleitung

Sharon Flanagan

Weitere Kernanwält*innen

Torrey Cope; Jon Olsen; James Johnson; Joshua Hofheimer; Frank Rahmani; Sally Wagner Partin